Conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
ACIP recommended Hib conjugate vaccine to all children at 18 months of age
On Jan. 22, 1988, the Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP) recommended…
Global Polio Eradication Initiative was launched as global burden of polio impacts 350,000 in 125 countries annually
In 1988, the World Health Assembly adopted a resolution for the worldwide eradication of polio, marking the launch…
The National Vaccine Injury Compensation Program (NVICP) was established
In 1988, the National Vaccine Injury Compensation Program (NVICP) was established to provide compensation following a vaccine-related adverse…
FDA approved Protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught)
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
U.S. Congress created the National Vaccine Program
On Nov. 14, 1986, the U.S. Congress created the National Vaccine Program (NVP) to coordinate the vaccine research…
Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed
On Jul. 23, 1986, the Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed. Using recombinant DNA…
Lorne Tyrrell discovered the first antiviral drug to inhibit hepatitis B virus
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
The National Childhood Vaccine Injury Act of 1986 was enacted by Congress
In 1986, the National Childhood Vaccine Injury Act was enacted by Congress. The Department of Health and Human…
Rotary International established its PolioPlus program
In 1985, Rotary International established its PolioPlus program, which held two fundraising events. Rotary has contributed over $500…
Center for Discovery and Innovation in Parasitic Diseases (CDIPD) was founded
In 1985, the CDIPD was founded as an NIH-NIAID-supported Tropical Disease Research Unit (TDRU) at University of California,…
The costs of hepatitis B vaccine and its administration became a covered benefit under Medicare Part B
On Sept. 1, 1984, with the enactment of P.L. 98-369 by the U.S. Congress, coverage under Part B…
Two enhanced pneumococcal polysaccharide vaccines were licensed
On Jun. 30, 1983, the U.S. Food and Drug Administration (FDA) licensed two enhanced pneumococcal polysaccharide vaccines (Pneumovax…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
The Foundation for the Advancement of Military Medicine was established
in May 1983, President Ronald Reagan signed into law a bill that established the Foundation for the Advancement…
Hollister-Stier Laboratories became a division of the Miles Pharmaceutical Group
In 1983, Hollister-Stier Laboratories became a division of the Miles Pharmaceutical Group. Hollister-Stier Laboratories, located in Spokane, was…
Artificial Intelligence | Biotechnology | Energy | Infectious Disease | Life Science News | Materials | Medical Device | Nanotechnology | U.S. Congress | Vaccine
The Small Business Innovation Research (SBIR) program was established by U.S. Congress
In 1982, the Small Business Innovation Research (SBIR) program, administered by the U.S. Small Business Administration (SBA), was…
The first recombinant DNA vaccine for livestock was developed
In 1982, the first recombinant DNA vaccine for livestock was developed. An advantage of the vaccines made through…
The first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were licensed Both had independently developed plasma-based hepatitis B viral vaccines
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
The CDC reported an all-time low of measles cases
In 1982, the U.S. Centers for Disease Control and Prevention (CDC) reported an all-time low of measles cases,…
Quadrivalent groups A, C, Y, and W-135 (Menomune A/C/Y/W-135 by Connaught) meningococcal vaccine was licensed
On Nov. 23, 1981, the U.S. Food and Drug Administration licensed Quadrivalent groups A, C, Y, and W-135…
The costs of pneumococcal vaccine and its administration became a covered benefit under Medicare Part B
On Jul. 1, 1981, as a result of the enactment of Public Law 96-611 passed by the U.S….
First human viral vaccine to prevent cancer (hepatitis B vaccine for liver cancer) was introduced
In 1981, the U.S. Food and Drug Administration (FDA) approved a plasma-derived hepatitis B vaccine for human use….
Biotechnology | CDC | Diagnostics | Influenza | Life Science News | Vaccine
CDC began collecting reports of influenza outbreaks from state and territorial epidemiologists
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) began collecting reports of influenza outbreaks from…
Biotechnology | Energy | Life Science History | Marine Science | Materials | Medicine | NIH | Non-Profit Research | U.S. Congress | Vaccine
Bayh-Dole Act passed the U.S. congress allowing universities to patent discoveries made in federally supported laboratories
On Dec. 12, 1980, a bill to amend title 35 of the United States Code (H.R.6933, Public Law:…
Rabies human diploid-cell vaccine (Imovax Rabies by Merieux and Wyvac by Wyeth) were licensed
On Jun. 9, 1980, the rabies human diploid-cell vaccine (Imovax Rabies by Merieux, now Sanofi, and Wyvac by…
The World Heath Organization announced that “smallpox has been eradicated from the world”
On May 8, 1980, members of the World Heath Organization (WHO) in Geneva announced that “smallpox had been…
Biotechnology | Diagnostics | Life Science News | Measles | Vaccine | WHO
The World Health Assembly certified the world free of naturally-occurring smallpox
On May 8, 1980, the World Health Assembly certified the world free of naturally-occurring smallpox. Smallpox is an…
The last cases of wild type 1 poliovirus occurred in the U.S.
On Jul. 27, 1979, the last cases of wild type 1 poliovirus occurred in the U.S. among unvaccinated…
The RA 27/3 (human diploid fibroblast) strain of rubella vaccine (Meruvax II by Merck) was licensed; all other strains discontinued
In 1979, the U.S. Food and Drug Administration (FDA) licensed the RA 27/3 (human diploid fibroblast) strain of…
The last wild case of polio was recorded in the U.S.
In 1979, the last wild case of polio was recorded in the U.S. However, in 1993, the virus…